Medovex Corp Stock Current Valuation
| HCYTDelisted Stock | USD 2.21 0.00 0.00% |
Valuation analysis of Medovex Corp helps investors to measure Medovex Corp's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
Please note that Medovex Corp's price fluctuation is very steady at this time. Calculation of the real value of Medovex Corp is based on 3 months time horizon. Increasing Medovex Corp's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Medovex otc stock is determined by what a typical buyer is willing to pay for full or partial control of Medovex Corp. Since Medovex Corp is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Medovex OTC Stock. However, Medovex Corp's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2.21 | Real 2.1 | Hype 2.21 | Naive 1.5 |
The intrinsic value of Medovex Corp's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Medovex Corp's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Medovex Corp helps investors to forecast how Medovex otc stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Medovex Corp more accurately as focusing exclusively on Medovex Corp's fundamentals will not take into account other important factors: Medovex Corp OTC Stock Current Valuation Analysis
Medovex Corp's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Medovex Corp Current Valuation | 8.88 M |
Most of Medovex Corp's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Medovex Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
CompetitionIn accordance with the recently published financial statements, Medovex Corp has a Current Valuation of 8.88 M. This is 99.94% lower than that of the Healthcare sector and 99.81% lower than that of the Biotechnology industry. The current valuation for all United States stocks is 99.95% higher than that of the company.
Medovex Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Medovex Corp's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Medovex Corp could also be used in its relative valuation, which is a method of valuing Medovex Corp by comparing valuation metrics of similar companies.Medovex Corp is currently under evaluation in current valuation category among its peers.
Medovex Fundamentals
| Return On Equity | -4.6 | |||
| Return On Asset | -3.48 | |||
| Operating Margin | (3.51) % | |||
| Current Valuation | 8.88 M | |||
| Shares Outstanding | 477.61 K | |||
| Shares Owned By Insiders | 25.51 % | |||
| Number Of Shares Shorted | 294 | |||
| Price To Earning | (1.53) X | |||
| Price To Book | 34.90 X | |||
| Price To Sales | 3.68 X | |||
| Revenue | 1.61 M | |||
| Gross Profit | 906.81 K | |||
| EBITDA | (4.61 M) | |||
| Net Income | (4.8 M) | |||
| Cash And Equivalents | 45.88 K | |||
| Cash Per Share | 0.16 X | |||
| Total Debt | 3.88 M | |||
| Debt To Equity | 2.61 % | |||
| Current Ratio | 0.04 X | |||
| Book Value Per Share | (17.98) X | |||
| Cash Flow From Operations | (4.81 M) | |||
| Short Ratio | 3.47 X | |||
| Earnings Per Share | (0.05) X | |||
| Target Price | 1.75 | |||
| Beta | 0.73 | |||
| Market Capitalization | 1.06 M | |||
| Total Asset | 321.4 K | |||
| Retained Earnings | (38.35 M) | |||
| Working Capital | 3.33 M | |||
| Current Asset | 4.18 M | |||
| Current Liabilities | 851.22 K | |||
| Net Asset | 321.4 K |
About Medovex Corp Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Medovex Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Medovex Corp using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Medovex Corp based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Consideration for investing in Medovex OTC Stock
If you are still planning to invest in Medovex Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Medovex Corp's history and understand the potential risks before investing.
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |